Biotech · Private company
Cerevance Beta, Inc.
Track this companyFree. Adds Cerevance Beta, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- CVN424 150 mgPhase 2 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- CVN424 High DosePhase 2 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- CVN424 Low DosePhase 2 · Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- CVN424Phase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- CVN424Phase 1 · Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Early Parkinson's Disease Monotherapy With CVN424PHASE2 · COMPLETED · started Sep 11, 2023ClinicalTrials.gov NCT06006247 · fetched Nov 12, 2026
- Relative Bioavailability and Food Effect Study of CVN424PHASE1 · COMPLETED · started Oct 9, 2022ClinicalTrials.gov NCT05635461 · fetched Nov 12, 2026
- Study of CVN424 in Parkinson's Disease Patients With Motor FluctuationsPHASE2 · COMPLETED · started Dec 2, 2019ClinicalTrials.gov NCT04191577 · fetched Nov 12, 2026
- Study of CVN424 in Healthy SubjectsPHASE1 · COMPLETED · started Sep 18, 2018ClinicalTrials.gov NCT03657030 · fetched Nov 12, 2026